Research Article

Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component

Table 1

The optimal thresholds for prognostic factors by the ROC curves.

VariablesThresholdSensitivitySpecificityAUC area (95% CI) value

Tumor size5.250.6670.6030.675 (0.617-0.732)<0.001
Leukocyte6.170.4890.6030.519 (0.457-0.580)0.557
Neutrophil3.310.5910.5170.552 (0.490-0.613)0.103
Hemoglobin125.10.6360.5110.573 (0.512-0.634)0.021
Fibrinogen3.310.5540.6030.595 (0.535-0.656)0.003
Albumin40.10.6490.5320.587 (0.526-0.648)0.006
Globulin29.20.2850.8080.522 (0.461-0.584)0.480
Platelet2430.5540.5830.567 (0.505-0.628)0.036
NLR1.60.7310.4170.583 (0.522-0.044)0.009
PLR1330.6080.6090.609 (0.549-0.670)0.001

; NLR = neutrophil-to-lymphocyte ratio; PLR = platelet-to-lymphocyte ratio.